Phio Pharmaceuticals Corp. (PHIO)

Phio Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	21.03	5.38	8.49	11.78	24.06
Cash & Short-Term Investments	21.03	5.38	8.49	11.78	24.06
Cash Growth	290.77%	-36.61%	-27.93%	-51.03%	68.89%
Other Current Assets	0.45	0.35	0.83	0.67	0.67
Total Current Assets	21.48	5.74	9.32	12.45	24.73
Net Property, Plant & Equipment	0.01	0	0.04	0.34	0.42
Other Long-Term Assets	-	-	0	0.02	0.03
Total Assets	21.49	5.74	9.36	12.81	25.17
Accounts Payable	0.44	0.25	0.66	0.78	0.28
Accrued Expenses	0.91	0.76	0.94	1.03	2.66
Current Portion of Leases	-	-	0.04	0.14	0.13
Total Current Liabilities	1.34	1.02	1.63	1.94	3.07
Long-Term Leases	-	-	-	0.04	0.17
Total Long-Term Liabilities	-	-	-	0.04	0.17
Total Liabilities	1.34	1.02	1.63	1.97	3.24
Common Stock	0	0	-	-	0
Additional Paid-in Capital	175.2	151.08	146.94	139.22	138.83
Retained Earnings	-155.05	-146.36	-139.21	-128.38	-116.9
Total Common Shareholders' Equity	20.15	4.72	7.73	10.84	21.93
Minority Interest	-	-	-	0	-
Shareholders' Equity	20.15	4.72	7.73	10.84	21.93
Total Liabilities & Equity	21.49	5.74	9.36	12.81	25.17
Total Debt	0	0	0.04	0.17	0.3
Net Cash (Debt)	21.03	5.38	8.46	11.61	23.76
Net Cash Growth	290.77%	-36.34%	-27.18%	-51.14%	74.69%
Net Cash Per Share	3.52	6.83	36.52	91.94	200.01
Book Value	20.15	4.72	7.73	10.84	21.93
Book Value Per Share	3.37	6.00	33.39	85.82	184.61
Tangible Book Value	20.15	4.72	7.73	10.84	21.93
Tangible Book Value Per Share	3.37	6.00	33.39	85.82	184.61

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q